Luke T. Izzo

Luke T. Izzo

Auto-generated profile, based on publicly available information

Luke T. Izzo

Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2020 in Nature
Verified
Journal Article
Closed access
PDF file
SZSteven Zhao
Steven Zhao
CJCholsoon Jang
Cholsoon Jang
JLJoyce Liu
Joyce Liu
KUKahealani Uehara
Kahealani Uehara
MGMichael Gilbert
Michael Gilbert
KWKathryn E. Wellen
Kathryn E. Wellen

23 October 2019 in Nature
Verified
Journal Article
Closed access
LILuke T. Izzo
Luke T. Izzo
KWKathryn E. Wellen
Kathryn E. Wellen

5 May 2023 in Science Advances
Verified
Journal Article
Open access
LILuke T. Izzo
Luke T. Izzo
STSophie Trefely
Sophie Trefely
CDChristina Demetriadou
Christina Demetriadou
JDJack M. Drummond
Jack M. Drummond
TMTakuya Mizukami
Takuya Mizukami
KWKathryn E. Wellen
Kathryn E. Wellen
The metabolite acetyl-CoA is necessary for both lipid synthesis in the cytosol and histone acetylation in the nucleus. The two canonical precursors to acetyl-CoA in the nuclear-cytoplasmic compartment are citrate and acetate, which are processed to acetyl-CoA by ATP-citrate lyase (ACLY) and acyl-CoA synthetase short-chain 2 (ACSS2), respectively. It is unclear whether other substantial routes to nuclear-cytosolic acetyl-CoA exist. To investigate this, we generated cancer cell lines lacking both ACLY and ACSS2 [double knockout (DKO) cells]. Using stable isotope tracing, we show that both glucose and fatty acids contribute to acetyl-CoA pools and histone acetylation in DKO cells and that acetylcarnitine shuttling can transfer two-carbon units from mitochondria to cytosol. Further, in the absence of ACLY, glucose can feed fatty acid synthesis in a carnitine responsive and carnitine acetyltransferase (CrAT)-dependent manner. The data define acetylcarnitine as an ACLY- and ACSS2-independent precursor to nuclear-cytosolic acetyl-CoA that can support acetylation, fatty acid synthesis, and cell growth.

1 December 2021 in Molecular Cell
Verified
Journal Article
Closed access
STSophie Trefely
Sophie Trefely
KHKatharina Huber
Katharina Huber
JLJoyce Liu
Joyce Liu
MNMichael Noji
Michael Noji
SSStephanie Stransky
Stephanie Stransky
NSNathaniel W. Snyder
Nathaniel W. Snyder

22 February 2022 in Oncogene
Verified
Journal Article
Closed access
PDF file
LCLorela Ciraku
Lorela Ciraku
ZBZachary A. Bacigalupa
Zachary A. Bacigalupa
JJJing Ju
Jing Ju
RMRebecca A. Moeller
Rebecca A. Moeller
GMGiang Le Minh
Giang Le Minh
MRMauricio J. Reginato
Mauricio J. Reginato

26 September 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
MWMargaret C. Weber
Margaret C. Weber
LILuke T. Izzo
Luke T. Izzo
TOTrudy G. Oliver
Trudy G. Oliver
Small-cell lung cancer (SCLC) is a neuroendocrine tumor type with limited treatment options and poor prognosis. SCLC comprises multiple molecular subtypes that are defined by the expression of the lineage-related transcription factors ASCL1, NEUROD1, POU2F3, and more controversially, YAP1. SCLC exhibits remarkable plasticity with the capacity to transition between molecular states; because these states are associated with unique therapeutic susceptibilities, SCLC has been likened to a moving therapeutic target. While MYC's role in driving the ASCL1-to-NEUROD1 (A-to-N) transition is established, additional mechanisms governing SCLC plasticity remain largely obscure. A recent study by Duplaquet and colleagues, published in Nature Cell Biology, employs an innovative genetically engineered mouse model of SCLC harboring loss of KDM6A—a histone lysine demethylase mutated in approximately 2% of SCLC cases. KDM6A loss in SCLC alters chromatin accessibility and increases the potential for A-to-N plasticity in vivo. Through characterization of the epigenetic landscape, Duplaquet and colleagues identified histone methylation as a key regulator of SCLC plasticity. These findings provide not only a new model system for studying SCLC plasticity, but also identify new epigenetic mechanisms involved, which will ultimately be critical for designing more effective therapies.